Your browser doesn't support javascript.
loading
Synergistic effect of PARP inhibitor and BRD4 inhibitor in multiple models of ovarian cancer.
Huang, Yuhan; Liu, Chen; You, Lixin; Li, Xi; Chen, Gang; Fan, Junpeng.
Afiliação
  • Huang Y; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu C; National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • You L; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li X; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Chen G; National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Fan J; Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Cell Mol Med ; 27(5): 634-649, 2023 03.
Article em En | MEDLINE | ID: mdl-36753396

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Cell Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Cell Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China